News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Gilead Sciences, Inc.
NEWS
JOBS
IN THE PRESS
NEWS
Biotech Bay
New Report Questions the Safety of Gilead’s Pricey Hep C Drugs
January 26, 2017
·
1 min read
Deals
Incyte Who? Why This Biotech Would Give Gilead a Bang for Its Buck
January 26, 2017
·
2 min read
Biotech Bay
3 Biotech Stocks To Buy And Hold Stress-Free
January 24, 2017
·
1 min read
Deals
Why the Government Should Pay $156 Billion to Own Gilead
January 17, 2017
·
2 min read
Business
Gilead: To Split or Not to Split...
January 12, 2017
·
2 min read
Deals
How Gilead Can Spend Its $32 Billion Stockpile to Reignite Investor Optimism
January 11, 2017
·
1 min read
Genetown
What Happens If You Considered Gilead A Startup
January 9, 2017
·
1 min read
Deals
Gilead’s New Hire Fuels Talk of an Acquisition
January 6, 2017
·
3 min read
Business
Gilead Poaches Cancer R&D Superstar From Novartis AG
January 4, 2017
·
3 min read
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Biotech Bay
European Commission (EC) Grants Marketing Authorization For Gilead’s Vemlidy (Tenofovir Alafenamide, TAF) For The Treatment Of Chronic Hepatitis B Virus Infection
January 11, 2017
·
8 min read
Biotech Bay
Gilead Release: Biotech Awards More Than $22 Million In Grants To Support HIV Cure Research
January 10, 2017
·
3 min read
Business
Creathor Venture Portfolio-Company Phenex Pharmaceuticals AG Receives 100 M USD Milestone Payment From Gilead
January 6, 2017
·
4 min read
Business
Phenex Pharmaceuticals AG Receives $100M Milestone Payment From Gilead
January 5, 2017
·
2 min read
Business
Landauer Comments On Gilead’s Nomination Of Directors
December 21, 2016
·
4 min read
FDA
Japan’s Ministry of Health, Labour And Welfare Approves Gilead’s Vemlidy For Patients With Chronic Hepatitis B Virus Infection
December 19, 2016
·
7 min read
Policy
Gilead Submits New Drug Application To The FDA For The Investigational Single Tablet Regimen Sofosbuvir/Velpatasvir/Voxilaprevir
December 8, 2016
·
3 min read
Drug Development
Gilead Announces Top-Line Results From Two Phase 3 Studies Evaluating Momelotinib For Patients With Myelofibrosis
November 17, 2016
·
5 min read
Business
Gilead Announces Promotion Of James R. Meyers To Executive Vice President, Worldwide Commercial Operations
November 17, 2016
·
2 min read
Business
Gilead Announces Promotion Of James R. Meyers To Executive Vice President, Worldwide Commercial Operations
November 17, 2016
·
2 min read
